Pelthos Therapeutics Inc. (PTHS) is a publicly traded Healthcare sector company. As of July 24, 2026, PTHS trades at $26.51 with a market cap of $98.71M and a P/E ratio of -1.20. PTHS moved -8.73% today. Year to date, PTHS is -5.71%; over the trailing twelve months it is +26.44%. Its 52-week range spans $13.76 to $54.29. Analyst consensus is strong buy with an average price target of $59.00. Rallies surfaces PTHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PTHS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PTHS recently traded at $26.51. Market cap is $98.71M. P/E ratio is -1.20. Revenue is $16.80M.
| Metric | Value |
|---|---|
| Price | $26.51 |
| Market Cap | $98.71M |
| P/E Ratio | -1.20 |
| EPS | $-23.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $54.29 |
| 52-Week Low | $13.76 |
| Volume | 205.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $16.80M |
| Net Income | $-43.32M |
| Gross Margin | 76.25% |
6 analysts cover PTHS: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $59.00.